The Latest Breaking News from PFE

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

The U.S. stock market brushed aside worries over a potential government shutdown and advanced on Tuesday. The Dow Jones Industrial Average gained nearly 0.2% to 46,397.89, the SP 500 climbed about 0.4% to 6,688.46, and the Nasdaq rose 0.3% to 22,660.These are the top stocks that gained the attention of…

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump administration health officials intend to link the vaccines to 25 child deaths. This assertion is reportedly based on unverified submissions to the Vaccine…

The Eurosceptic group has collected enough signatures to kick off a motion of censure. Von der Leyen will face Parliament’s verdict in October.

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults.

The radical Left and far-right are about to present two different motions of censure against the Commission. A first vote is expected in October.

The group that includes France’s Rassemblement National, Italy’s The League, and Hungary’s Fidesz could be obliged to repay over €4 million.

Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.

Senator Bernie Sanders (I-VT) called for Health and Human Services Secretary Robert F. Kennedy Jr.‘s resignation on Saturday, citing Kennedy’s “dangerous policies” that are “endangering the health of the American people.”